Search Our Website:
menu

NEWARK

550 Broad Street, Suite 810

Newark, NJ 07102-4582

DATE
TITLE
CONTRIBUTORS
SERVICES & INDUSTRIES
FEB 23 2026

CSC Issues Guidance on NIL Enforcement as the Transfer Portal Heats Up

ANDREW G. HOPE JORDYNN E. JACKSON
ANTITRUST & TRADE REGULATION EDUCATION LITIGATION NAME, IMAGE, AND LIKENESS (NIL)
FEB 13 2026

Massachusetts Introduces Legislation to Regulate Pharmacy Benefit Managers

CAITLIN M. COLLINS LUCAS W. MORGAN
PBM AUDIT DEFENSE & CONTRACT SERVICES STATE BOARD OF PHARMACY: PROACTIVE & HOLISTIC COUNSEL
FEB 12 2026

New Jersey Appellate Division Clarifies Scope of Ending Forced Arbitration of Sexual Assault and Harassment Act

CHRISTOPHER J. DALTON JOHN L. LAMB
LABOR & EMPLOYMENT
FEB 12 2026

Sweeping PBM Reforms Arrive: What the 2026 Federal Legislation Means for Pharmacies, Patients and Employers

CAITLIN M. COLLINS LUCAS W. MORGAN
PBM AUDIT DEFENSE & CONTRACT SERVICES STATE BOARD OF PHARMACY: PROACTIVE & HOLISTIC COUNSEL
FEB 9 2026

Oral Semaglutide and the GLP-1 Compounding Reckoning: From Regulatory Ambiguity to FDA Enforcement, DOJ Referrals, and Novo Nordisk’s Case Against Hims & Hers

DAE Y. LEE LUCAS W. MORGAN
STATE BOARD OF PHARMACY: PROACTIVE & HOLISTIC COUNSEL
FEB 5 2026

Key Amendments to Arizona Laws Impacting the Pharmacy Industry

CAITLIN M. COLLINS LUCAS W. MORGAN
STATE BOARD OF PHARMACY: PROACTIVE & HOLISTIC COUNSEL
JAN 26 2026

California’s PBM Fiduciary Law Faces an ERISA Challenge – Why This Matters for Independent Pharmacies and Patients

DAE Y. LEE LUCAS W. MORGAN
PBM AUDIT DEFENSE & CONTRACT SERVICES
JAN 21 2026

A Pivotal Moment for Patients and Independent Pharmacies: Congress Acts on PBM Reform with Bipartisan Legislation

DAE Y. LEE LUCAS W. MORGAN
PBM AUDIT DEFENSE & CONTRACT SERVICES
JAN 21 2026

Recent Case Illustrates Challenges for Independent Pharmacies in Seeking Access to Largest PBM Networks

CAITLIN M. COLLINS LUCAS W. MORGAN
PBM AUDIT DEFENSE & CONTRACT SERVICES STATE BOARD OF PHARMACY: PROACTIVE & HOLISTIC COUNSEL
JAN 20 2026

New Wave of ERISA Class Action Lawsuits Name Brokers as Defendants

DAE Y. LEE
PBM AUDIT DEFENSE & CONTRACT SERVICES
JAN 12 2026

National Pharmacy Benefit Manager Implements Direct-to-Consumer Model

CAITLIN M. COLLINS DAE Y. LEE
PBM AUDIT DEFENSE & CONTRACT SERVICES
JAN 8 2026

When Pass-Through Isn’t Pass-Through: PBM GPOs and the Reengineering of Rebates

DAE Y. LEE
PBM AUDIT DEFENSE & CONTRACT SERVICES
DEC 23 2025

Year-End and Early-Year PBM Network Enforcement: Why Pharmacies Must Stay Vigilant Right Now

DAE Y. LEE
PBM AUDIT DEFENSE & CONTRACT SERVICES
DEC 22 2025

Federal Legislation Enhances Pharmacist Role in Prescribing Buprenorphine

CAITLIN M. COLLINS LUCAS W. MORGAN
STATE BOARD OF PHARMACY: PROACTIVE & HOLISTIC COUNSEL
DEC 19 2025

Missouri Moves for Fairness and Transparency for Pharmacy Benefit Managers

CAITLIN M. COLLINS LUCAS W. MORGAN
PBM AUDIT DEFENSE & CONTRACT SERVICES
DEC 18 2025

OptumRx Follows Other PBMs’ Playbooks: Therapeutic Class Caps Signal the Next Phase of PBM Oversight

DAE Y. LEE LUCAS W. MORGAN
PBM AUDIT DEFENSE & CONTRACT SERVICES
DEC 16 2025

Compounded GLP-1 Advertising: What Compounders Need to Know NOW

DAE Y. LEE LUCAS W. MORGAN
PBM AUDIT DEFENSE & CONTRACT SERVICES
DEC 12 2025

PBMs as De Facto Regulators: A 2025 Recap of PBM Audits and Their Growing Impact on Board of Pharmacy Enforcement

DAE Y. LEE
PBM AUDIT DEFENSE & CONTRACT SERVICES
DEC 12 2025

Clarifying Antitrust Requirements for NIL-Era Eligibility Challenges

ANDREW G. HOPE DAVID A. GURWIN JORDYNN E. JACKSON
ANTITRUST & TRADE REGULATION EDUCATION LITIGATION NAME, IMAGE, AND LIKENESS (NIL)
DEC 9 2025

A New Era for Independent Pharmacies in New Jersey: Leveling the Playing Field with PBM Reforms

CAITLIN M. COLLINS LUCAS W. MORGAN
PBM AUDIT DEFENSE & CONTRACT SERVICES STATE BOARD OF PHARMACY: PROACTIVE & HOLISTIC COUNSEL
NOV 26 2025

Recent Updates Transforming Plan Sponsor Relationships with Pharmacy Benefit Managers

DAE Y. LEE
PBM AUDIT DEFENSE & CONTRACT SERVICES
NOV 26 2025

Kentucky Pharmacies: Prepare for USP Changes in the New Year

CAITLIN M. COLLINS LUCAS W. MORGAN
STATE BOARD OF PHARMACY: PROACTIVE & HOLISTIC COUNSEL
NOV 25 2025

Bridging the Gap: Maine’s New Law Empowers Pharmacies and Pharmacists to Improve Rural Access to Medications

CAITLIN M. COLLINS LUCAS W. MORGAN
STATE BOARD OF PHARMACY: PROACTIVE & HOLISTIC COUNSEL
NOV 25 2025

State PBM Oversight Has Been Growing But Enforcement Still Falls Short: Why Pharmacies Must Step Up

DAE Y. LEE
PBM AUDIT DEFENSE & CONTRACT SERVICES
NOV 24 2025

EEOC Issues Directive to Close All Pending Charges Alleging Only Disparate Impact in the Wake of Trump’s April 23 Executive Order

CHRISTOPHER J. DALTON JOSHUA M. CLARK MICHAEL J. KINCADE, JR.
LABOR & EMPLOYMENT
NOV 14 2025

Cigna’s Rebate-Free Model: What It Really Means for Plan Sponsors, Pharmacies and the Industry

DAE Y. LEE
PBM AUDIT DEFENSE & CONTRACT SERVICES STATE BOARD OF PHARMACY: PROACTIVE & HOLISTIC COUNSEL
NOV 12 2025

California Enacts New Law Requiring California Licensure for Pharmacists-in-Charge of Nonresident Pharmacies — Effective July 1, 2026

CAITLIN M. COLLINS LUCAS W. MORGAN
STATE BOARD OF PHARMACY: PROACTIVE & HOLISTIC COUNSEL
OCT 29 2025

Ohio Court Expands NIL Rights to High School Athletes

ANDREW G. HOPE DAVID A. GURWIN JORDYNN E. JACKSON
EDUCATION LITIGATION NAME, IMAGE, AND LIKENESS (NIL)
OCT 28 2025

Illinois to Require Illinois-Licensed PICs for Nonresident Pharmacies Effective January 1, 2026

CAITLIN M. COLLINS LUCAS W. MORGAN
STATE BOARD OF PHARMACY: PROACTIVE & HOLISTIC COUNSEL
OCT 23 2025

California’s Governor Signs New Pharmacy Benefit Manager Law into Effect

CAITLIN M. COLLINS LUCAS W. MORGAN
PBM AUDIT DEFENSE & CONTRACT SERVICES STATE BOARD OF PHARMACY: PROACTIVE & HOLISTIC COUNSEL
OCT 23 2025

The Alabama Board of Pharmacy: What Licensees Need to Know About Rule 680-X-2-.40 Ahead of the November 19 Hearing/Meeting

CAITLIN M. COLLINS LUCAS W. MORGAN
PBM AUDIT DEFENSE & CONTRACT SERVICES STATE BOARD OF PHARMACY: PROACTIVE & HOLISTIC COUNSEL
OCT 15 2025

The PBM Effect: Regulatory and Market Implications for Life Sciences Companies and Healthcare Providers

DAE Y. LEE LUCAS W. MORGAN
HEALTHCARE LIFE SCIENCES PBM AUDIT DEFENSE & CONTRACT SERVICES
OCT 14 2025

Ohio’s PBM Regulation Passed by House of Representatives

CAITLIN M. COLLINS LUCAS W. MORGAN
PBM AUDIT DEFENSE & CONTRACT SERVICES STATE BOARD OF PHARMACY: PROACTIVE & HOLISTIC COUNSEL
OCT 14 2025

Update: Status of FTC Case Against Three Largest PBMs

CAITLIN M. COLLINS LUCAS W. MORGAN
PBM AUDIT DEFENSE & CONTRACT SERVICES STATE BOARD OF PHARMACY: PROACTIVE & HOLISTIC COUNSEL
OCT 8 2025

TrumpRx: What Pharmacies and Plan Sponsors Need to Know

DAE Y. LEE NATALIE C. OEHLERS
LABOR & EMPLOYMENT LIFE SCIENCES PBM AUDIT DEFENSE & CONTRACT SERVICES STATE BOARD OF PHARMACY: PROACTIVE & HOLISTIC COUNSEL
SEP 26 2025

Ohio Legislatures Introduce Bill to Regulate PBMs

CAITLIN M. COLLINS LUCAS W. MORGAN
PBM AUDIT DEFENSE & CONTRACT SERVICES STATE BOARD OF PHARMACY: PROACTIVE & HOLISTIC COUNSEL
SEP 25 2025

AstraZeneca Doubles Down: Pharmacies Face Escalated Requests for Farxiga® Dispensing Records

DAE Y. LEE
PBM AUDIT DEFENSE & CONTRACT SERVICES STATE BOARD OF PHARMACY: PROACTIVE & HOLISTIC COUNSEL
SEP 24 2025

NCAA Eligibility Update: Sixth Circuit Scrutinizes Junior College Transfer Rules

ANDREW G. HOPE JORDYNN E. JACKSON
EDUCATION LITIGATION NAME, IMAGE, AND LIKENESS (NIL)
SEP 22 2025

Corresponding Responsibility: Why Pharmacies Must Take It Seriously — And How a Mock DEA Audit Can Protect Your Business

DAE Y. LEE KELLY A. REYNOLDS
PBM AUDIT DEFENSE & CONTRACT SERVICES
SEP 18 2025

Iowa’s PBM Oversight Laws: What Independent Pharmacies Need to Know

DAE Y. LEE LUCAS W. MORGAN
PBM AUDIT DEFENSE & CONTRACT SERVICES STATE BOARD OF PHARMACY: PROACTIVE & HOLISTIC COUNSEL
SEP 10 2025

A Turning Point for Fiduciary Accountability: PBM-Owned Rebate Aggregators in the Spotlight

DAE Y. LEE
PBM AUDIT DEFENSE & CONTRACT SERVICES
SEP 9 2025

FTC Moves to Drop Defense of Non-Compete Clause Rule, but Non-Compete Agreements Remain of Interest

CARRIE G. AMEZCUA ERIN J. MCLAUGHLIN VINCENT N. BARBERA WILLIAM C. BOAK
ANTITRUST & TRADE REGULATION LABOR & EMPLOYMENT LITIGATION
SEP 2 2025

Milking the Clock: Legal Challenges to the NCAA’s Five-Year Rule in the NIL Era

ANDREW G. HOPE DAVID A. GURWIN JORDYNN E. JACKSON
ANTITRUST & TRADE REGULATION LABOR & EMPLOYMENT LITIGATION NAME, IMAGE, AND LIKENESS (NIL)
AUG 26 2025

A Hard-Fought Victory: Overturning a Medicare Revocation for a Pennsylvania Pharmacy

DAE Y. LEE KELLY A. REYNOLDS
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
AUG 25 2025

Legal Updates on Arkansas Law Banning PBMs From Owning Affiliated Pharmacies

CAITLIN M. COLLINS LUCAS W. MORGAN
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
AUG 25 2025

Buchanan Pharmacy Attorneys Reverse 100% of PBM Audit Findings

DAE Y. LEE KELLY A. REYNOLDS
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
AUG 6 2025

PBM Audits: Assessment of Escalating Trends and Strategies for Pharmacies

DAE Y. LEE
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
AUG 5 2025

Major Update on GLP-1 Litigation involving Compounding Pharmacies

DAE Y. LEE LUCAS W. MORGAN NATALIE P. CROW
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
JUL 28 2025

PBMs Double Down on Cross Network Termination over “Affiliated” Pharmacies

DAE Y. LEE
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
JUL 25 2025

From Eligibility to Enforcement: How Law and Policy Are Shaping College Athletics

ANDREW G. HOPE DAVID A. GURWIN JORDYNN E. JACKSON
ANTITRUST & TRADE REGULATION LABOR & EMPLOYMENT LITIGATION NAME, IMAGE, AND LIKENESS (NIL) TITLE IX
JUL 23 2025

Foul Play Off the Field: DOJ Indicts Sports Executive in Texas Bid-Rigging Scheme

CARRIE G. AMEZCUA JORDYNN E. JACKSON
ANTITRUST & TRADE REGULATION LITIGATION
JUL 22 2025

The 340B Drug Pricing Program: Navigating Challenges in Healthcare Access

CAITLIN M. COLLINS DAE Y. LEE LUCAS W. MORGAN
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
JUL 22 2025

New Rules to Impact Texas Pharmacies

CAITLIN M. COLLINS DAE Y. LEE LUCAS W. MORGAN
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
JUL 18 2025

Victory for DMEPOS Provider: Buchanan Reverses Medicare Enrollment Revocation

DAE Y. LEE
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
JUN 30 2025

Turning the Tide on Prior Authorization: A Legal and Strategic Moment for Independent Pharmacies

DAE Y. LEE
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
JUN 27 2025

Ohio Board of Pharmacy Prescribes New Rules for Ohio Pharmacies

LUCAS W. MORGAN
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
JUN 23 2025

Seven County Infrastructure Coalition et al. v. Eagle County, Colorado et al.: An Important U.S. Supreme Court Decision on the Scope of Judicial Review of NEPA Environmental Impact Statements

AMANDA L. WETZEL JAMES O'TOOLE, JR.
ENERGY ENVIRONMENTAL LITIGATION
JUN 17 2025

Pharmacy Alert: AstraZeneca Sends “Unreserved Cooperation” Letters Demanding Farxiga® Dispensing Records

DAE Y. LEE
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
JUN 12 2025

State Board of Pharmacy: Ohio GLP-1 Compounders Be Vigilant

CAITLIN M. COLLINS DAE Y. LEE LUCAS W. MORGAN
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
JUN 5 2025

Growing Concern for Pennsylvania Pharmacies: The Surge in State Board Inspections and the Collateral Impact on PBM Relationships

DAE Y. LEE LUCAS W. MORGAN
LIFE SCIENCES
MAY 29 2025

PBMs Under Siege: How the Current Administration’s 2025 Executive Order and FTC Enforcement Campaign Are Shaping the Future of Drug Pricing

DAE Y. LEE
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
MAY 15 2025

Pharmacies on Alert: Gilead Reports Pharmacies to State Boards Over Counterfeit Drug Purchases

DAE Y. LEE LUCAS W. MORGAN
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
MAY 14 2025

Tirzepatide Ruling: Implications for Compounders in an Evolving Legal Landscape

DAE Y. LEE LUCAS W. MORGAN NATALIE P. CROW
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
MAY 13 2025

Why Pharmacies Must Stay Vigilant on PBM Provider Manual Updates

DAE Y. LEE
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
MAY 7 2025

PBMs Clamp Down on Diabetic Test Supply Sourcing: Invoice Shortages and Network Terminations on the Rise

DAE Y. LEE
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
MAY 5 2025

Michigan’s Lawsuit Against Express Scripts and Prime Therapeutics Signals a Turning Point for Independent Pharmacies, Plan Sponsor, Patients, and State Enforcement

CARRIE G. AMEZCUA DAE Y. LEE
ANTITRUST & TRADE REGULATION FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
MAY 2 2025

A Blueprint for Action: Michigan’s Lawsuit Against Express Scripts and Prime Therapeutics Signals a Turning Point for Independent Pharmacies, Plan Sponsor, Patients, and State Enforcement

CARRIE G. AMEZCUA DAE Y. LEE
LIFE SCIENCES PBM AUDIT DEFENSE & CONTRACT SERVICES
MAY 1 2025

Mixed Messages? New DEI Executive Order Seeks to Eliminate Disparate-Impact Theory

AMANDA M. SCARPO CHRISTOPHER J. DALTON JAIME S. TUITE
GOVERNMENT RELATIONS & PUBLIC POLICY LABOR & EMPLOYMENT
APR 28 2025

Traditional PBM Model Is Not Suitable For Employers

DAE Y. LEE
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
APR 25 2025

GLP-1 Litigation Escalates: What Pharmacies and Telemedicine Providers Need to Know

DAE Y. LEE LUCAS W. MORGAN
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
APR 17 2025

The High Cost of Trust: What Pharmacies Must Learn from the Rise of Counterfeit GLP-1 Product Sales

DAE Y. LEE NATALIE P. CROW
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
APR 8 2025

Navigating DEA Red Flags and Corresponding Responsibilities: A Stark Reality for Today’s Pharmacies

DAE Y. LEE
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
APR 4 2025

Wells Fargo’s ERISA Dismissal and Johnson & Johnson’s Second Try: The Stakes for Employer Fiduciaries

DAE Y. LEE
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
MAR 28 2025

Buying or Selling a Pharmacy? Here's What You Need to Know Before the Deal Closes

DAE Y. LEE
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
MAR 27 2025

The End of CTA Reporting Requirements for US Companies

BRIAN S. NORTH CINDY DUNLAP HINKLE JARED R. JOHNSON JENNIFER M. RODRIGUEZ ROBIN L. DIERBECK STEVEN W. SMITH
CORPORATE SECURITIES & SEC TAX
MAR 27 2025

PBM Audits: Lessons from First Quarter of 2025 and What Pharmacies Must Prepare for Next

DAE Y. LEE
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
MAR 19 2025

Navigating Medicaid Drug Rebate Program (MDRP) Compliance: A Guide for Pharmaceutical Manufacturers

DAE Y. LEE
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
MAR 18 2025

PBMs Are Becoming Legal Risks for Employers

DAE Y. LEE
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
MAR 12 2025

Florida’s PBM Contract Attestation Requirement: What Self-Funded Employers Need to Know

DAE Y. LEE
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
MAR 5 2025

CTA Reporting Obligations Will Not Be Enforced Against Domestic Reporting Companies

BRIAN S. NORTH CINDY DUNLAP HINKLE JARED R. JOHNSON JENNIFER M. RODRIGUEZ ROBIN L. DIERBECK STEVEN W. SMITH
CORPORATE SECURITIES & SEC TAX
MAR 3 2025

Johnson & Johnson Lawsuit Dismissal Changes Nothing! Health Plan Fiduciaries Must Stay Vigilant Over Pharmacy Benefit Management

DAE Y. LEE
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
FEB 28 2025

FDA’s Removal of Semaglutide and the Evolving Tirzepatide Decisions: What Compounders Need to Know

DAE Y. LEE NATALIE P. CROW
FDA & BIOTECHNOLOGY
FEB 24 2025

A Fresh Look at HIPAA’s Security Rule: What to Expect from HHS’ Notice of Proposed Rulemaking

ANDRIA R. ADIGWE, CIPP/US JACQUELINE V. JONCZYK, CIPP/US
CYBERSECURITY & DATA PRIVACY HEALTHCARE LITIGATION
FEB 20 2025

Corporate Transparency Act Reporting Back On (For Now)

BRIAN S. NORTH CINDY DUNLAP HINKLE JARED R. JOHNSON JENNIFER M. RODRIGUEZ ROBIN L. DIERBECK STEVEN W. SMITH
CORPORATE SECURITIES & SEC TAX
FEB 18 2025

Recent Developments in New Jersey and New York Are Likely to Increase AI Driven Employment-Discrimination Litigation

CHRISTOPHER J. DALTON MINJI KIM
ADVANCED TECHNOLOGY CLASS ACTIONS CYBERSECURITY & DATA PRIVACY GOVERNMENT RELATIONS & PUBLIC POLICY LABOR & EMPLOYMENT
FEB 13 2025

How We Helped a New York Pharmacy Avoid PBM Network Termination – And What You Can Learn From It

DAE Y. LEE
FDA & BIOTECHNOLOGY LIFE SCIENCES PBM AUDIT DEFENSE & CONTRACT SERVICES
FEB 3 2025

The 2024 EPA PFAS Regulations, EPA PFAS Enforcement Priorities, and Reopener Risks

ALEX M. PEARLSTEIN AMANDA L. WETZEL JAMES O'TOOLE, JR. LOUIS M. DESTEFANO
ENVIRONMENTAL
JAN 27 2025

FinCEN Suspends CTA Enforcement Despite Supreme Court Ruling

BRIAN S. NORTH CINDY DUNLAP HINKLE JARED R. JOHNSON JENNIFER M. RODRIGUEZ ROBIN L. DIERBECK STEVEN W. SMITH
CORPORATE SECURITIES & SEC TAX
JAN 27 2025

Tirzepatide, FDA, and Compounding: Understanding the Current Landscape

DAE Y. LEE NATALIE P. CROW
FDA & BIOTECHNOLOGY LIFE SCIENCES PBM AUDIT DEFENSE & CONTRACT SERVICES
JAN 22 2025

Navigating the FDA’s Final Interim Policy on Compounding with Bulk Drug Substances: A Guide for 503A Pharmacies and 503B Outsourcing Facilities

DAE Y. LEE NATALIE P. CROW TINA HU-RODGERS
FDA & BIOTECHNOLOGY LIFE SCIENCES PBM AUDIT DEFENSE & CONTRACT SERVICES
JAN 10 2025

Newly Issued Final Regulations for Clean Hydrogen: Key Takeaways

ALAN M. SELTZER CARL F. STAIGER JAMES O'TOOLE, JR. JOHN F. POVILAITIS SEAN W. MORAN
ENERGY TAX
NOV 15 2023

Understanding The FDA's Current Focus On Risk Evaluation And Mitigation Strategies

FDA & BIOTECHNOLOGY LIFE SCIENCES
SEP 5 2023

Workplace Protections in a Post-Pandemic World: Federal Court Decision Applies New Jersey Law to Remote Out-of-State Employee

CHRISTOPHER J. DALTON
LABOR & EMPLOYMENT
AUG 21 2023

NLRB Adopts New Standard for Evaluating the Legality of Work Rules

ERIN J. MCLAUGHLIN JILL M. LASHAY MICHAEL J. KINCADE, JR. WILLIAM P. LEWIS
LABOR & EMPLOYMENT
JUL 12 2023

Workplace Vaccine Requirements Lead to Jump in EEOC Religious Discrimination Charges

ANTHONY (T.J.) ANDRISANO JILL M. LASHAY
LABOR & EMPLOYMENT
JUN 22 2023

New York Moves Closer to Banning Employee Non-Compete Agreements

ERIN J. MCLAUGHLIN
LABOR & EMPLOYMENT
MAY 30 2023

New Jersey Appellate Division Adopts Bright-Line Rule: Class Action Waivers Unenforceable Absent Mandatory Arbitration Agreement

CHRISTOPHER J. DALTON SAMANTHA L. SOUTHALL
CLASS ACTIONS LITIGATION
APR 25 2023

Effective July 2023: Song-Beverly Act Amendment Will Affect Companies Selling Consumer Goods in California

CHRISTOPHER J. DALTON JENNIFER M. OLIVER, CIPP/US
CLASS ACTIONS CONSUMER PRODUCTS LITIGATION
FEB 17 2023

US Department of Labor Issues New Guidance on Obligations Owed To Remote Workers

ERIN J. MCLAUGHLIN JAIME S. TUITE
LABOR & EMPLOYMENT
FEB 17 2023

Significant Implications for Staffing Agencies, Employers Under NJ Temporary Workers’ Bill of Rights

CHRISTOPHER J. DALTON
LABOR & EMPLOYMENT
JAN 25 2023

What Employers Need to Know About New York’s Adult Survivors Act

CHRISTOPHER J. DALTON JASON P. BOLOGNA
LABOR & EMPLOYMENT LITIGATION WHITE COLLAR DEFENSE, COMPLIANCE & INVESTIGATIONS
JAN 19 2023

New Jersey WARN Act Amendments To Take Effect April 10, 2023

CHRISTOPHER J. DALTON
LABOR & EMPLOYMENT
JAN 13 2023

Federal Contractor Vaccine Mandate Blocked by the Fifth Circuit

ERIN J. MCLAUGHLIN
CORONAVIRUS (COVID-19) LABOR & EMPLOYMENT
JAN 11 2023

Top Tips for Managing a Multi-State Workforce

ERIN J. MCLAUGHLIN
LABOR & EMPLOYMENT TAX
JAN 9 2023

Attention New Jersey Employers: Amendments to NJ WARN Act Significantly Expanding Scope of Coverage Awaiting Governor’s Signature

CHRISTOPHER J. DALTON
LABOR & EMPLOYMENT
JAN 6 2023

FTC Takes Legal Action Against Employee Noncompete Agreements; Issues Three Complaints and Proposed Ban

CARRIE G. AMEZCUA ERIN J. MCLAUGHLIN MARK A. KASTEN
ANTITRUST & TRADE REGULATION LABOR & EMPLOYMENT LITIGATION TRADE SECRETS & RESTRICTIVE COVENANTS
DEC 20 2022

Session-Replay Software and Chat Wiretapping Lawsuits: A New Wave of Litigation for Companies With an Online Presence

ARGIA J. DIMARCO CHRISTOPHER J. DALTON JENNIFER M. OLIVER, CIPP/US SAMANTHA L. SOUTHALL
CLASS ACTIONS LITIGATION
OCT 3 2022

Proposed New Jersey Legislation Calls for Equal Pay For Temporary Workers

ERIN J. MCLAUGHLIN MICHAEL J. KINCADE, JR.
LABOR & EMPLOYMENT
NOV 6 2020

New Jersey Jury Trials in the Age of COVID-19

ALEXIS ALOI GRAZIANO
CORONAVIRUS (COVID-19) LITIGATION
MAY 13 2020

Pandemic Induced Class Actions Taking Hold Across the US

ANDREW G. HOPE CHRISTOPHER J. DALTON
CLASS ACTIONS CORONAVIRUS (COVID-19) LITIGATION
APR 14 2020

New Jersey Passes New Laws in Response to COVID-19

MICHAEL D. HALL
CORONAVIRUS (COVID-19) LABOR & EMPLOYMENT LITIGATION
FEB 3 2020

NJ Enacts Several New Employment Laws

CHRISTOPHER J. DALTON MICHAEL D. HALL
LABOR & EMPLOYMENT
DEC 26 2019

New Jersey Expands Law Against Discrimination to Protect Race-Based Hairstyles

CHRISTOPHER J. DALTON
LABOR & EMPLOYMENT LITIGATION
JAN 3 2018

Minimum Wage Increases Now in Effect

KIMBERLY AROUH
LABOR & EMPLOYMENT
OCT 9 2017

Seventh Circuit Holds That Extension of A Medical Leave Is Not A Reasonable Accommodation

LABOR & EMPLOYMENT
APR 5 2011

The New Jersey Law Against Discrimination Now Requires Religious Accommodation in the Workplace

 
LABOR & EMPLOYMENT
APR 5 2011

New Jersey Set to Become the Third State with Paid Family Leave

 
LABOR & EMPLOYMENT
APR 5 2011

NJ Rule Extends Transfer Tax to Certain Corporate Transactions

REAL ESTATE
APR 5 2011

Can a Health Care Employer in New Jersey Refuse to Hire a Smoker?

LABOR & EMPLOYMENT
APR 5 2011

Resident Admission Agreements in New Jersey

 
APR 5 2011

Changes in Corporate Business Tax Will Increase Costs of Doing Business in New Jersey

 
TAX
APR 5 2011

Identity Theft — The Tide Keeps Rising — Part II

DAVID A. GURWIN
TECHNOLOGY, LICENSING AND COMMERCIAL CONTRACTS